Estudio comparativo entre el BTA stat test, NMP-22 y citología en el diagnóstico del cáncer vesical

Archivos Espanoles de Urologia

Volumn 53, Issue 1, 2000, Pages 21-27

  Baños, José Luis Gutiérrez ^a,b   Rodrigo, María Del Henar Rebollo ^a   Juarez, Francisco Antolín ^a   García, Bernardo Martín ^a   Rodríguez, Rafael Hernández ^a   Martín, José Antonio Portillo ^a   Gómez, Miguel Angel Correas ^a   Schaan, Jose Ignacio Del Valle ^a   Edreira, Antonio Roca ^a   Rodríguez, Enrique De Diego ^a   Velázquez, Miguel Ángel Rado ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Hospital Universitario Valdecilla ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER TUMOR ASSOCIATED ANTIGEN; BLADDER TUMOR-ASSOCIATED ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

AGED; ANALYTICAL EQUIPMENT; ARTICLE; BLADDER TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; HUMAN; PATHOLOGY; SENSITIVITY AND SPECIFICITY; URINE;

AGED; ANTIGENS, NEOPLASM; HUMANS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0012775246     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. CATALONA, W.J.; "Bladder cancer." In: Adult and Paediatric Urology, 2nd ed. Edited by J.Y. Gillenwater, J.T. Grayhack, S.S. Howards and J.W. Duckett. St. Louis: Mosby Year Book, vol 1, chapt. 31, pp. 1135-1184, 1991.
2. LOENING, S.; NARAYANA, A.; YODER, L. y cols.: "Factors influencing the recurrence rate of bladder cancer." J. Urol., 123: 29, 1980.
3. TORTI, F.M.; LUM, B.L.; ASTON, D. y cols., "Superficial bladder cancer: the primacy of grade in the development of invasive disease." J. Clin. Oncol., 5: 125, 1987.
4. JORDAN, A.M.; WEINGARTEN, J.; MURPHY, W.M.: "Transitional cell neoplasm of the urinary bladder. Can biological potential be predicted from histologic grading?" Cancer, 60: 2766, 1987.
5. NOGUEIRA, M.J.: "Actualización en el tratamiento del tumor vesical superficial." Mesa redonda. Simposium sobre tumores vesicales superficiales. VI Reunión del grupo Uro-Oncológico de la AEU. Valencia. 1987.
6. PÁEZ, A.; LUJÁN, M.; MARTÍN, E. y cols.: "Alternativas al control cistoscópico de los tumores vesicales." Arch. Esp. Urol., 50: 1079, 1997.
7. MURPHY, W.M.: "Current status of urinary cytology in the evaluation of bladder neoplasm." Hum. Path., 21: 886, 1990.
8. SERVER FALGAS, G.: "Citología por lavado en el seguimiento de las neoplasias vesicales. Arch. Esp. Urol., 42: 523, 1989.
9. MORALES, A.; LEÓN, E.; MAESTRO, J.L. y cols.: "Ecografía y citología versus cistoscopia en el seguimiento de los enfermos con tumores vesicales superficiales." Actas Urol. Esp., 13: 436, 1989.
10. SALINAS, A.; SOLE, J.; TOMÉ, M. y cols.: "La citología urinaria para el diagnóstico y seguimiento de los tumores de vejiga." Actas Urol. Esp., 11: 47, 1987.
11. CARVELL, J.M.; PÉREZ, M.; GARCÍA, G.: "La citología en orina obtenida por micción espontánea. Su utilidad en el seguimiento de los tumores vesicales." Actas Urol. Esp., 13: 32, 1989.
12. CUMMINGS, K.B.; BARONES, J.G.; WARDS, W.S.: "Diagnosis and staging of bladder cancer." Urol. Clin. North Am., 19: 455, 1992.
13. HALECHMI, S.; LINN, J.F.; AMIEL, G.E. y cols.: "Urinary cytology, tumour markers and bladder cancer." Br. J. Urol., 82: 647, 1998.
14. STEIN, J.P.; GROSSFELD, G.; FINSBERG, D. y cols.: "Prognostic markers in bladder cancer: a contemporary review of the literature." J. Urol., 160: 645, 1998.
15. DROLLER, M.J.: "Editorial: Markers in bladder cancer. Issues to consider." J. Urol., 160: 2009, 1998.
16. GUTIÉRREZ, J.L.; MARTÍN, B.; HERNÁNDEZ, R. y cols.: "Utilidad del BTA stat test (Bard) en el diagnóstico del cáncer vesical. Resultados preliminares y comparación con citología y cistoscopia." Arch. Esp. Urol., 51: 778, 1998.
17. AMERICAN JOINT COMMITTEE ON CANCER: "Staging of cancer at genitourinary sites." In: American Joint Committee on Cancer: Manual for Staging of Cancer, 3rd Edition. Philadelphia: J:B. Lippincott co., pp. 194-195, 1988.
18. MOSTOFI, F.K.: "Histological Typing of Urinary Bladder Tumours." Geneva: World Health Organization, 1973.
19. SOLOWAY, M.; BRIGGMAN, J.; CARPINITO, G. y cols.: "Use of a new tumour marker, urinary NMP-22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment." J. Urol., 156: 363, 1996.
20. BEREZNEY, R.; COFFEY, D.S.: "Identification of a nuclear protein matrix." Biochem. Biophys. Res. Commun., 60: 1410, 1974.
21. BEREZNEY, R.; COFFEY, D.S.: "Nuclear protein matrix: association with newly synthesized DNA." Science, 189: 291, 1975.
22. FEY, E.G.; BANGS, P.; SPARKS, C. y cols.: "The nuclear matrix: defining structural and functional roles." Crit. Rev. Eukaryotic Gene Expr., 1: 127, 1991.
23. GETZENBERG, R.H.: "The nuclear matrix and the regulation of gene expression. Tissue specificity." J. Cell. Biochem., 55: 22, 1984.
24. VAN DER POEL, H.G.; WITJES, J.A.; VAN STRATUM, P. y cols.: "Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer." Urology, 48: 357, 1996.
25. **25. SERRETTA, V.; LO PRESTI, D.; VASILE, P. y cols.: "Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients." Urology, 52: 793, 1998.
26. MIYANAGA, N.; AKAZA, H.; ISHIKAWA, S. y cols.: "Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer." Eur. Urol., 31: 163, 1997.
27. ARIS, G.; THEODOROS, M.; ANNE, K. y cols.: "NMP22 as a urinary tumour marker of bladder cancer. A comparative study with BTA stat test and voided urine cytology (VUC)." Eur. Urol., 35 (suppl. 2): 131 abstract 522, 1999.
28. WITJES, J.A.; VAN DER POEL, H.G.; VAN BALKEN, M.R. y cols.: "Urinary NMP22 and karyometry in the diagnosis and follow up of patients with superficial bladder cancer." Eur. Urol., 33: 387, 1998.
29. LANDMAN, J.; CHANG, Y.; KAVALER, E. y cols.: "Sensitivity and specificity of NMP-22, telomerase and BTA in the detection of human bladder cancer." Urology, 52: 398, 1998.
30. DEL NERO, A.; ESPOSITO, N.; CURRÒ, A. y cols.: "Evaluation of urinary level of NMP-22 as a diagnostic marker for stage pTa-pTl bladder cancer: comparison with urinary cytology and BTA test." Eur. Urol., 35: 93, 1999.
31. STAMPFER, D.; CARPINITO, G.; RODRÍGUEZ- VILLANUEVA, J. y cols.: "Evaluation of NMP-22 in the detection of transitional cell carcinoma of the bladder." J. Urol., 159: 394, 1998.
32. HASAN, B.; SINAN, S.; USTUNOL, K. y cols.: "Comparison of the nuclear matrix protein 22 (NMP22) with voided urine cytology and BTA stat lest in the diagnosis of transitional cell carcinoma of the bladder." Eur. Urol., 35 (suppl. 2): 131 abstract 524, 1999.
33. SAROSDY, M.; HUDSON, M.; ELLIS, W. y cols.: "Improved detection of recurrent bladder cancer using the Bard BTA stat test." Urology, 50: 349, 1997.
34. WILLIAM, E.; LEURA, I.: "A comparison of BTA stat and the BTA trak assays: two new tests for the detection of recurrent bladder cancer in urine." Eur. Urol., 33 (suppl. 1): 140, abstract 558, 1998.
35. LEYH, H.; TRIBER, U.; MARBERGER, M. y cols.: "European multicenter trial comparing BTA stat test to urine cytology in patients suspected of having bladder cancer." Eur. Urol., 33 (suppl. 1): 140, abstract 559, 1998.
36. LEY, H.; MARBERGER, M.; CONORT, P. y cols.: "Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer." Eur. Urol., 35: 52, 1999.
37. IRANI, J.; DESGRANDCHAMPS, F.; MILLET, C. y cols.: "BTA stat and BTA trak: a comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder." Eur. Urol., 35: 89, 1999.